Abstract
Background
Array Comparative Genomic Hybridization (aCGH) is a widely used technique to assess chromosomal copy number alterations. Chromosomal content, however, is often not uniform throughout cell populations. Here we evaluated to what extent aCGH can detect DNA copy number alterations in heterogeneous cell populations. A systematic evaluation is currently lacking, despite its importance in diagnostics and research. The detection limits reported are a compound of analytical software and laboratory techniques and do not account for the number of probes in relation to sample homogeneity.
Methods
Detection limits were explored with DNA isolated from a patient with intellectual disability (ID) and from tumor cell line BT474. Both were diluted with increasing amounts of normal DNA to simulate different levels of cellularity. Samples were hybridized on microarrays containing 180,880 oligonucleotides evenly distributed over the genome (spacing ~17 kb).
Results
Single copy number alterations, represented by down to 249 probes (4 Mb) and present in 10 % of a cell population, could be detected. Alterations encompassing as few as 14 probes (~238 Kb) could also be detected, but for this a 35 % mosaic level was required.
Conclusions
DNA copy number alterations can be detected in cell populations containing 10 % abnormal cells. Detection of sub-megabase alterations requires a higher percentage of abnormal cells or microarrays with a higher probe density.
Similar content being viewed by others
Abbreviations
- aCGH:
-
Array comparative genome hybridization
- WCP:
-
Whole chromosome paint
- CEP:
-
Centromere probe
- FISH:
-
Fluorescence in situ hybridization
- GEO:
-
Gene expression omnibus
- CNV:
-
Copy number variation
- ID:
-
Intellectual disability
References
A.E. Oostlander, G.A. Meijer, B. Ylstra, Microarray-based comparative genomic hybridization and its applications in human genetics. Clin. Genet. 66, 488–495 (2004)
L.E. Vissers, B.B. de Vries, J.A. Veltman, Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis. J Med Genet. 47(5), 289–297 (2010)
D. Pinkel, D.G. Albertson, Array comparative genomic hybridization and its applications in cancer. Nat. Genet. 37(Suppl), S11–S17 (2005)
K. Wang, J. Li, S. Li, L. Bolund, C. Wiuf, Estimation of tumor heterogeneity using CGH array data. BMC Bioinforma. 10, 12 (2009)
C. Curtis, A.G. Lynch, M.J. Dunning, I. Spiteri, J.C. Marioni, J. Hadfield, S.F. Chin, J.D. Brenton, S. Tavaré, C. Caldas, The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics. 10, 588 (2009)
B.C. Ballif, E.A. Rorem, K. Sundin, M. Lincicum, S. Gaskin, J. Coppinger, C.D. Kashork, L.G. Shaffer, B.A. Bejjani, Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet Part A 140A, 2757–2767 (2006)
S.W. Cheung, C.A. Shaw, D.A. Scott, A. Patel, T. Sahoo, C.A. Bacino, A. Pursley, J. Li, R. Erickson, A.L. Gropman, D.T. Miller, M.R. Seashore, A.M. Summers, P. Stankiewicz, A.C. Chinault, J.R. Lupski, A.L. Beaudet, V.R. Sutton et al., Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet Part A 143A, 1679–1686 (2007)
C. Garnis, B.P. Coe, S.L. Lam, C. MacAulay, W.L. Lam, High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples. Genomics 85(6), 790–793 (2005)
N.A. Johnson, R.A. Hamoudi, K. Ichimura, L. Liu, D.M. Pearson, V.P. Collins, M.Q. Du, Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells. Lab Invest 86, 968–978 (2006)
J.R. Vermeesch, C. Melotte, G. Froyen, V.S. Van, B. Dutta, N. Maas, S. Vermeulen, B. Menten, F. Speleman, M.B. De, H.P. Van, P. Marynen, J.P. Fryns, K. Devriendt, Molecular karyotyping: array CGH quality criteria for constitutional genetic diagnosis. J. Histochem. Cytochem. 53, 413–422 (2005)
B. Ylstra, P. van den Ijssel, B. Carvalho, R.H. Brakenhoff, G.A. Meijer, BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res. 34(2), 445–450 (2006)
D. Pinto, K. Darvishi, X. Shi, D. Rajan, D. Rigler, T. Fitzgerald, A.C. Lionel, B. Thiruvahindrapuram, J.R. Macdonald, R. Mills, A. Prasad, K. Noonan, S. Gribble, E. Prigmore, P.K. Donahoe, R.S. Smith, J.H. Park, M.E. Hurles, N.P. Carter, C. Lee, S.W. Scherer, L. Feuk, Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat. Biotechnol. 29(6), 512–520 (2011)
J.R. González, B. Rodríguez-Santiago, A. Cáceres, R. Pique-Regi, N. Rothman, S.J. Chanock, L. Armengol, L.A. Pérez-Jurado, A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data. BMC Bioinforma. 12, 166 (2011)
S.A. Scott, N. Cohen, T. Brandt, G. Toruner, R.J. Desnick, L. Edelmann, Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. Genet Med. 12(2), 85–92 (2010)
R. Valli, C. Marletta, B. Pressato, G. Montalbano, F. Lo Curto, F. Pasquali, E. Maserati, Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells. Mol. Cytogenet. 4, 13 (2011)
K. Szuhai, I. Jennes, D. de Jong, J.V. Bovée, M. Wiweger, W. Wuyts, P.C. Hogendoorn, Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum. Mutat. 32(2), E2036–E2049 (2011). doi:10.1002/humu.21423
E.S. Venkatraman, A.B. Olshen, A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23(6), 657–663 (2007)
O. Krijgsman, D. Israeli, J.C. Haan, H.F. van Essen, S.J. Smeets, P.P. Eijk, M. Steenbergen RD, K. Kok, S. Tejpar, G.A. Meijer, B. Ylstra, CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material. Gene. Chromosome. Canc. 51(4), 344–352 (2012). doi:10.1002/gcc.21920
T.E. Buffart, D. Israeli, M. Tijssen, S.J. Vosse, A. Mrsić, G.A. Meijer, B. Ylstra, Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations. Gene. Chromosome. Canc. 47(11), 994–1004 (2008)
K. Jong, E. Marchiori, A. van der Vaart, S.F. Chin, B. Carvalho, M. Tijssen, P.P. Eijk, P. van den Ijssel, H. Grabsch, P. Quirke, J.J. Oudejans, G.A. Meijer, C. Caldas, B. Ylstra, Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 26(10), 1499–1506 (2007)
D.J. Venter, S.J. Ramus, F.M. Hammet, M. de Silva, A.M. Hutchins, V. Petrovic, G. Price, J.E. Armes, Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines. Canc. Genet. Cytogenet. 160(2), 134–140 (2005)
D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W.L. Kuo, C. Chen, Y. Zhai, S.H. Dairkee, B.M. Ljung, J.W. Gray, D.G. Albertson, High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20(2), 207–211 (1998)
M.A. van de Wiel, K.I. Kim, S.J. Vosse, W.N. van Wieringen, S.M. Wilting, B. Ylstra, CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 23(7), 892–894 (2007)
B.P. Coe, B. Ylstra, B. Carvalho, G.A. Meijer, C. Macaulay, W.L. Lam, Resolving the resolution of array CGH. Genomics 89(5), 647–653 (2007)
N.P. Carter, Methods and strategies for analyzing copy number variation using DNA microarrays. Nat. Genet. 39(7 Suppl), S16–S21 (2007)
R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, M. Urashima, K.T. Mc Henry, R.M. Pinchback, A.H. Ligon, Y.J. Cho, L. Haery, H. Greulich, M. Reich, W. Winckler, M.S. Lawrence, B.A. Weir, K.E. Tanaka, D.Y. Chiang, A.J. Bass, A. Loo, C. Hoffman, J. Prensner, T. Liefeld, Q. Gao, D. Yecies, S. Signoretti, E. Maher, F.J. Kaye, H. Sasaki, J.E. Tepper, J.A. Fletcher, J. Tabernero, J. Baselga, M.S. Tsao, F. Demichelis, M.A. Rubin, P.A. Janne, M.J. Daly, C. Nucera, R.L. Levine, B.L. Ebert, S. Gabriel, A.K. Rustgi, C.R. Antonescu, M. Ladanyi, A. Letai, L.A. Garraway, M. Loda, D.G. Beer, L.D. True, A. Okamoto, S.L. Pomeroy, S. Singer, T.R. Golub, E.S. Lander, G. Getz, W.R. Sellers, M. Meyerson, The landscape of somatic copy-number alteration across human cancers. Nature 463(7283), 899–905 (2010)
R.J. Leary, J.C. Lin, J. Cummins, S. Boca, L.D. Wood, D.W. Parsons, S. Jones, T. Sjöblom, B.H. Park, R. Parsons, J. Willis, D. Dawson, J.K. Willson, T. Nikolskaya, Y. Nikolsky, L. Kopelovich, N. Papadopoulos, L.A. Pennacchio, T.L. Wang, S.D. Markowitz, G. Parmigiani, K.W. Kinzler, B. Vogelstein, V.E. Velculescu, Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 105(42), 16224–16229 (2008)
R. Redon, S. Ishikawa, K.R. Fitch, L. Feuk, G.H. Perry, T.D. Andrews, H. Fiegler, M.H. Shapero, A.R. Carson, W. Chen, E.K. Cho, S. Dallaire, J.L. Freeman, J.R. González, M. Gratacòs, J. Huang, D. Kalaitzopoulos, D. Komura, J.R. MacDonald, C.R. Marshall, R. Mei, L. Montgomery, K. Nishimura, K. Okamura, F. Shen, M.J. Somerville, J. Tchinda, A. Valsesia, C. Woodwark, F. Yang, J. Zhang, T. Zerjal, J. Zhang, L. Armengol, D.F. Conrad, X. Estivill, C. Tyler-Smith, N.P. Carter, H. Aburatani, C. Lee, K.W. Jones, S.W. Scherer, M.E. Hurles, Global variation in copy number in the human genome. Nature 444(7118), 444–454 (2006)
S.J. Smeets, U. Harjes, W.N. van Wieringen, D. Sie, R.H. Brakenhoff, G.A. Meijer, B. Ylstra, To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!Clin. Cancer Res. 17(15), 4959–4964 (2011)
T.E. Buffart, B. Carvalho, T. Mons, R.M. Reis, C. Moutinho, P. Silva, N.C. van Grieken, M. Vieth, M. Stolte, C.J. van de Velde, E. Schrock, A. Matthaei, B. Ylstra, F. Carneiro, G.A. Meijer, DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics. 8, 345 (2007)
X.Y. Goh, J.R. Rees, A.L. Paterson, S.F. Chin, J.C. Marioni, V. Save, M. O'Donovan, P.P. Eijk, D. Alderson, B. Ylstra, C. Caldas, R.C. Fitzgerald, Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut 60(10), 1317–1326 (2011)
H.F. van Essen, B. Ylstra, High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues. Meth. Mol. Biol. 838, 329–341 (2012)
O. De Wever, M. Mareel, Role of tissue stroma in cancer cell invasion. J. Pathol. 200(4), 429–447 (2003)
N.P. West, M. Dattani, P. McShane, G. Hutchins, J. Grabsch, W. Mueller, D. Treanor, P. Quirke, H. Grabsch, The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br. J. Cancer 102(10), 1519–1523 (2010)
W.E. Mesker, J.M. Junggeburt, K. Szuhai, P. de Heer, H. Morreau, H.J. Tanke, R.A. Tollenaar, The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell. Oncol. 29(5), 387–398 (2007)
K. Tanaka, D. Yamamoto, M. Yamada, H. Okugawa, Influence of cellularity in human breast carcinoma. Breast 13(4), 334–340 (2004)
Y. Wu, H. Grabsch, T. Ivanova, I.B. Tan, J. Murray, C. H. Ooi, A. I. Wright, N. P. West, G. G. Hutchins, J. Wu, M. Lee, J. Lee, J. H. Koo, K. G. Yeoh, N. van Grieken, B. Ylstra, S. Y. Rha, J. A. Ajani, J.H. Cheong, S.H. Noh, K.H. Lim, A. Boussioutas, J.S. Lee, P. Tan. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut. (2012 Jun 26). [Epub ahead of print]
S.F. Chin, A.E. Teschendorff, J.C. Marioni, Y. Wang, N.L. Barbosa-Morais, N.P. Thorne, J.L. Costa, S.E. Pinder, M.A. van de Wiel, A.R. Green, I.O. Ellis, P.L. Porter, S. Tavaré, J.D. Brenton, B. Ylstra, C. Caldas, High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol. 8(10), R215 (2007)
Acknowledgements
This study was supported by the VUmc Institute for Cancer and Immunology (VUmc CCA/V-ICI) and performed within the framework of CTMM, the Center for Translational Molecular Medicine, DeCoDe project (grant 03O-101). We would like to thank Els Voorhoeve from the VU university medical center for collecting the samples.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary_Figure 1
Chromosome 5 profile of BT474. aCGH profiles of a gain at the p-arm of chromosome 5 in BT474 with 100 %, 30 % and 20 % tumor DNA. (JPEG 95 kb)
Supplementary_Figure 2
Dilution range of BT474 DNA on the NimbleGen platform. Profiles of all dilutions of BT474 DNA were performed on the NimbleGen platform. (PNG 203 kb)
Supplementary_Figure 3
aCGH profiles for CNVR3771/2 on chromosome 8 in a patient with ID. Panel A shows an overview of chromosome 8 in the undiluted sample. Panels B–D show the detection of CNVR3771/2 (DNA loss) in dilutions to 35 %, 30 % and 25 % patient DNA. CNVR3771/2 (21 probes, ~1 Mb) could be detected with dilutions down to 35 % and 30 %, but not with 25 % patient DNA. The genomic locations of both CNVs are indicated in B. The X-axis represents the genomic locations (in Mb), and the Y-axis represents the log2 ratios for each probe. Grey lines represent the CBS segments [17]. (JPEG 94 kb)
Supplementary_Figure 4
HER2/neu amplification in BT474. aCGH profiles of an amplification at 17q12 (30 probes, ~0.3 Mb), which includes HER2/neu. Hybrizations were performed with 100 %, 20 % and 10 % tumor DNA. The X-axis represents the chromosomal locations, and the Y-axis the log2 ratios. Grey lines represent the CBS segments [17]. (JPEG 120 kb)
Rights and permissions
About this article
Cite this article
Krijgsman, O., Israeli, D., van Essen, H.F. et al. Detection limits of DNA copy number alterations in heterogeneous cell populations. Cell Oncol. 36, 27–36 (2013). https://doi.org/10.1007/s13402-012-0108-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-012-0108-2